Reference number : 236-2013-2014-Q4-00071, amendment number : , agreement type : G, recipient legal name : BENNETT, Steffany A, recipient country : CA, recipient province : ON, recipient city : Ottawa, recipient postal code : K1N 6N5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 778945.0, agreement start date : 2014-04-01, agreement end date : 2019-03-31, description english : Aberrant phospholipid and sphingolipid metabolism is a primary and targetable pathology in Alzheimer Disease, description french : Aberrant phospholipid and sphingolipid metabolism is a primary and targetable pathology in Alzheimer Disease, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2014-15 to 2018-19), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2014-15 à 2018-19), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada